<SEC-DOCUMENT>0001437749-12-011655.txt : 20121114
<SEC-HEADER>0001437749-12-011655.hdr.sgml : 20121114
<ACCEPTANCE-DATETIME>20121114113924
ACCESSION NUMBER:		0001437749-12-011655
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20121114
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20121114
DATE AS OF CHANGE:		20121114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GeoVax Labs, Inc.
		CENTRAL INDEX KEY:			0000832489
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				870455038
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-52091
		FILM NUMBER:		121202069

	BUSINESS ADDRESS:	
		STREET 1:		1900 LAKE PARK DRIVE
		STREET 2:		SUITE 380
		CITY:			SMYRNA
		STATE:			2Q
		ZIP:			30080
		BUSINESS PHONE:		678-384-7220

	MAIL ADDRESS:	
		STREET 1:		1900 LAKE PARK DRIVE
		STREET 2:		SUITE 380
		CITY:			SMYRNA
		STATE:			2Q
		ZIP:			30080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Geovax Labs, Inc.
		DATE OF NAME CHANGE:	20061002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAUPHIN TECHNOLOGY INC
		DATE OF NAME CHANGE:	19940826

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SUCCESSO INC
		DATE OF NAME CHANGE:	19910410
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>geovax_8k-111412.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html>
<head>
    <title>geovax_8k-111412.htm</title>
    <!--Licensed to: RDG-->
    <!--Document Created using EDGARizerAgent 5.4.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div>
<hr style="COLOR: black" align="left" noshade size="3" width="100%">
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 18pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">WASHINGTON, D.C. 20549</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div>
<hr style="COLOR: black" align="center" noshade size="2" width="15%">
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 18pt; FONT-WEIGHT: bold">FORM 8-K</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CURRENT REPORT</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Pursuant to Section 13 or 15(d) of the</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Securities Exchange Act of 1934</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Date of report (Date of earliest event reported):&#160;&#160;November 14, 2012</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div>
<hr style="COLOR: black" align="center" noshade size="2" width="15%">
</div>

</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 18pt; FONT-WEIGHT: bold">GEOVAX LABS, INC.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Exact name of registrant as specified in Charter)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="25%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Delaware</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="25%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">000-52091</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="25%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">87-0455038</font></div>
</td>
</tr><tr>
<td valign="top" width="25%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(State or other jurisdiction of</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">incorporation or organization)</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="25%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Commission File No.)</font></div>
</td>
<td align="left" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></td>
<td valign="top" width="25%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(IRS Employee Identification No.)</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1900 Lake Park Drive</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Suite 380</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Smyrna, Georgia 30080</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Address of Principal Executive Offices)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(678) 384-7220</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(Issuer Telephone number)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions (see General Instruction A.2 below).</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">[&#160;&#160;] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">[&#160;&#160;] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR240.14a-12)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">[&#160;&#160;] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">[&#160;&#160;] Pre-commencement communications pursuant to Rule 13e-4&#169; under the Exchange Act (17 CFR 240.13(e)-4(c))</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font>

<div>
<hr style="COLOR: black" align="left" noshade size="3" width="100%">
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This Form 8-K and other reports filed by GeoVax Labs, Inc. (the &#8220;registrant&#8221;) from time to time with the Securities and Exchange Commission (collectively the &#8220;Filings&#8221;) contain forward looking statements and information that are based upon beliefs of, and information currently available to, the registrant's management as well as estimates and assumptions made by the registrant's management.&#160;&#160;When used in the Filings the words &#8220;anticipate&#8221;, &#8220;believe&#8221;, &#8220;estimate&#8221;, &#8220;expect&#8221;, &#8220;future&#8221;, &#8220;intend&#8221;, &#8220;plan&#8221; or the negative if these terms and similar expressions as they relate to the registrant or the registrant's management identify forward looking statements.&#160;&#160;Such statements reflect the current view of the registrant with respect to future events and are subject to risks, uncertainties, assumptions and other factors relating to the registrant's industry, operations and results of operations and any businesses that may be acquired by the registrant.&#160;&#160;Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 2.02&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Results of Operations and Financial Condition</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On November 14, 2012 we issued a press release reporting our results of operations for the quarter ended September 30, 2012.&#160;&#160;A copy of the press release is attached to this Current Report.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 9.01&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial Statements and Exhibits</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 72pt"></font>Exhibit 99.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Press Release</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURES</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 72pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dated:&#160;&#160;November 14, 2012</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 207pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 216pt"></font>GEOVAX LABS, INC.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 207pt"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 207pt"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 207pt"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 207pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 216pt"></font>By:<font style="DISPLAY: inline; TEXT-DECORATION: underline">&#160;&#160;&#160;/s/ Mark W. Reynolds</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 207pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 216pt"></font>&#160;&#160;&#160;&#160;&#160;Mark W. Reynolds</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 207pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 216pt"></font>&#160;&#160;&#160;&#160;&#160;Chief Financial Officer</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 207pt"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 207pt"><br>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
<head>
    <title>ex99-1.htm</title>
    <!--Licensed to: RDG-->
    <!--Document Created using EDGARizerAgent 5.4.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-WEIGHT: bold">Exhibit 99.1<br>
</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><img src="logo.jpg" alt=""></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">GeoVax Reports 2012 Third Quarter Financial Results</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">ATLANTA, GA, November 14, 2012 </font>&#8211; GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing vaccines to prevent and treat HIV/AIDS, announced its financial results for the nine months ended September 30, 2012 and provided a business update.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GeoVax&#8217;s President and CEO Robert McNally, Ph.D., commented, &#8220;The third quarter of 2012 was very active for GeoVax as it marked the completion of the Phase 2a trial (HVTN 205) of our preventive HIV/AIDS vaccine.&#160;&#160;Results of this trial were presented in September by the HIV Vaccine Trials Network (HVTN) at the AIDS Vaccine 2012 Conference in Boston.&#160;&#160;HVTN 205 confirmed our Phase 1 results, with our vaccines demonstrating an excellent safety profile and reproducible T cell and antibody immune responses.&#160;&#160;We expect publication of the full study results in the near future.&#160;&#160;The stage is now set for a Phase 2b efficacy trial, to commence after completion of the ongoing Phase 1 trial testing the safety of our second-generation product that co-expresses HIV proteins and granulocyte-macrophage colony-stimulating factor (GM-CSF) in the DNA prime.&#8221;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dr. McNally continued, &#8220;With regard to the use of our vaccines for therapeutic treatment of individuals already infected with HIV, patient recruitment for our Phase 1/2 &#8216;treatment interruption&#8217; clinical trial is on track for full enrollment by the end of 2012.&#160;&#160;We are also planning a Phase 1 trial to investigate the use of our vaccine in combination with standard-of-care drug therapy in HIV-positive young adults; we expect this trial to commence in early 2013 with sponsorship by the International Maternal Pediatric Adolescent AIDS Clinical Trial Group (IMPAACT) and with financial support from the National Institutes of Health (NIH).&#8221;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;Additionally,&#8221; Dr. McNally said, &#8220;We received a $1.9 million funding commitment from the NIH to begin the extension of our vaccine technology to cover clade C infections, the HIV subtype most prevalent in the developing world.&#8221;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">David Dodd, GeoVax&#8217;s Chairman of the Board, remarked, &#8220;We are pleased that GeoVax continues to progress with the most promising vaccine candidates for preventing and treating HIV/AIDS.&#160;&#160;To date, our vaccines provide the strongest evidence of potential success in this global challenge to public health.&#160;&#160;As a result, GeoVax&#8217;s success, progress and leadership in this field are increasingly recognized throughout the scientific and life sciences business communities.&#8221;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Financial Review</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GeoVax reported a net loss of $296,779 ($0.02 per share) for the three months ended September 30, 2012, compared to $375,852 ($0.02 per share) for the same period in 2011. For the nine months ended September 30, 2012, the Company&#8217;s net loss was $1,525,055 ($0.09 per share) as compared to $1,193,478 ($0.08 per share) in 2011.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Company reported revenues of $638,000 and $2,197,761 for the three-month and nine-month periods of 2012, respectively, related to its grants from the NIH. As of September 30, 2012, there is approximately $3.7 million in unused grant funds remaining and available for use.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Research and development (R&amp;D) expenses were $601,690 and $2,386,460 for the three-month and nine- month periods of 2012, respectively. R&amp;D expenses include direct costs funded by GeoVax&#8217;s Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) grant, as well as vaccine manufacturing costs and expenses related to the Phase 1/2 clinical trial of the Company&#8217;s therapeutic vaccine being sponsored by GeoVax. Costs associated with the Phase 2a clinical trial of GeoVax&#8217;s preventative HIV vaccine and the Phase 1 trial of the adjuvanted vaccine, being conducted by the HVTN, are funded directly by the NIH and are not reflected in GeoVax&#8217;s financial statements.&#160;&#160;General and administrative (G&amp;A) expenses were $334,166 and $1,339,300 for the three-month and nine-month periods of 2012, respectively.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">MORE</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GeoVax, Inc.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Add 1</font></div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GeoVax reported cash balances of $1,583,819 at September 30, 2012. Summarized financial information is presented below. Further information concerning the Company&#8217;s financial position and results of operations are included in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">About GeoVax&#8217;s Technology</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">GeoVax&#8217;s unique two-component vaccine, a recombinant DNA and a recombinant modified vaccinia Ankara (MVA), is designed to stimulate both anti-HIV T cell and anti-HIV antibody immune responses. GeoVax&#8217;s DNA and MVA vaccines are used in a prime/boost protocol in which priming is done with the DNA and boosting with the MVA. Both the DNA and MVA express the three major proteins of the AIDS virus: Gag, Pol, and Env, and produce noninfectious virus-like-particles. GeoVax&#8217;s vaccines are unique in expressing virus-like particles that display the trimeric membrane bound form of the HIV-1 envelope glycoprotein. In GeoVax&#8217;s second-generation vaccine, the DNA prime co-expresses GM-CSF with the virus-like particles, delivering a normal human protein that stimulates immune responses to the site of vaccination. All preventative Phase 1 human clinical trials conducted to date tested various combinations and doses of our DNA and MVA vaccines, their ability to raise anti-HIV humoral (antibody) and cellular (cytotoxic T cell) immune responses, as well as the vaccines&#8217; safety.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">About HIV/AIDS</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">AIDS is an epidemic that can affect anyone, regardless of race, gender, age or sexual orientation. There are 33 million people currently infected globally and it is estimated that there will be 2.5 million new infections this year. Since the beginning of the epidemic, over a million people in the U.S. have contracted the virus. Every 9&#189; minutes, someone in the U.S. is infected with AIDS. Globally, HIV is the top killer among women of reproductive age. HIV is a worldwide disease with different subtypes (or clades) of the virus predominating in different regions of the world. Clade B is the predominant subtype in North America. Globally, most infections involve subtypes AG, B and C. GeoVax vaccines are currently designed to function against clade B.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">For more information, please visit <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; TEXT-DECORATION: underline">www.geovax.com</font>.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Forward-Looking Statements</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certain statements in this document are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: HVTN will commence, complete enrollment, and generate data regarding GeoVax vaccine clinical trials as and when expected, GeoVax can develop and manufacture its vaccines with the desired characteristics in a timely manner, GeoVax's vaccines will be safe for human use, GeoVax's vaccines will effectively prevent AIDS in humans, vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete vaccine development, there is development of competitive products that may be more effective, less costly, or easier to use than GeoVax's products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking statements, and does not intend to do so. More information about these factors is contained in GeoVax's filings with the Securities and Exchange Commission including those set forth at "Risk Factors" in GeoVax's Form 10-K.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Contact:</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dian Griesel Inc.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Dillon Heins, Investor Relations</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Susan Forman or Laura Radocaj, Public Relations</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(212) 825-3210</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">MORE</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GeoVax, Inc.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Add 2</font></div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GEOVAX LABS, INC.</font></div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Condensed Consolidated Statements of Operations Information</font></div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(amounts in thousands, except per share data)</font></div>
</div>

<div>
<div>&#160;</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="44%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="6" valign="bottom" width="26%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -10.5pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Three Months Ended</font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30,</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="6" valign="bottom" width="26%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Nine Months Ended</font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">September 30,</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="44%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="44%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: -27pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Revenues</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="12%">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="12%">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="12%">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" width="12%">&#160;</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="44%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Grant Revenue</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 7.5pt"></font>638</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 9.5pt"></font>1,297</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 7pt"></font>2,198</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.85pt"></font>3,943</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="44%">&#160;</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="44%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Operating expenses:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="44%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Research and development</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">602</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,090</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,387</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,314</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="44%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">General and administrative</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">334</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">583</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,339</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,824</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="44%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">936</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,673</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3,726</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">5,138</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="44%">&#160;</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="44%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other income:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="44%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Interest income</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="44%" style="PADDING-BOTTOM: 2px">&#160;</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">-</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">3</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="44%">&#160;</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="44%" style="PADDING-BOTTOM: 4px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Net loss</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 7.5pt"></font>(297</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5pt"></font>(376</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 2.5pt"></font>(1,525</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.85pt"></font>(1,193</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="44%">&#160;</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="11%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="44%" style="PADDING-BOTTOM: 4px">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Loss per common share</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 7.5pt"></font>(0.02</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 5pt"></font>(0.02</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 7pt"></font>(0.09</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 4.85pt"></font>(0.08</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">)</font></td>
</tr></table>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">GEOVAX LABS, INC.</font></div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Condensed Balance Sheet Information</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(amounts in thousands)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px">&#160;</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Sep. 30,</font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2012</font></div>
</td>
<td nowrap valign="bottom" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Dec. 31,</font></font></div>

<font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2011</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Assets:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="bottom">&#160;</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Cash and cash equivalents</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,584</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,168</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other current assets</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">295</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">250</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total current assets</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 18.05pt"></font>1,879</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 20.3pt"></font>1,418</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%">&#160;</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Property, net</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">121</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">176</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Other assets</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">36</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">51</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total assets</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,036</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,645</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td valign="bottom" width="70%">&#160;</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Liabilities and stockholders&#8217; equity</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Current liabilities</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">338</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">941</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 2px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Stockholders&#8217; equity</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,698</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 2px solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">704</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="70%" style="PADDING-BOTTOM: 4px; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Total liabilities and stockholders&#8217; equity</font></div>
</td>
<td align="left" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">2,036</font></td>
<td nowrap valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">$</font></td>
<td valign="bottom" width="12%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">1,645</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left; PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="70%">&#160;</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#c0ffff">
<td align="left" valign="bottom" width="70%" style="PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Shares Outstanding</font></div>
</td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 11.35pt"></font>18,733</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="12%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font id="TAB1" style="MARGIN-LEFT: 13.6pt"></font>16,443</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>

<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">###</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<TEXT>
begin 644 logo.jpg
M_]C_X``02D9)1@`!`@$`2`!(``#_[0U<4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``2`````$``0!(`````0`!.$))300-```````$````>#A"24T#\P``
M````"```````````.$))300*```````!```X0DE-)Q````````H``0``````
M```".$))30/U``````!(`"]F9@`!`&QF9@`&```````!`"]F9@`!`*&9F@`&
M```````!`#(````!`%H````&```````!`#4````!`"T````&```````!.$))
M30/X``````!P``#_____________________________`^@`````________
M_____________________P/H`````/____________________________\#
MZ`````#_____________________________`^@``#A"24T$`````````@`!
M.$))300"```````$`````#A"24T$"```````$`````$```)````"0``````X
M0DE-!!0```````0````".$))300,``````NN`````0```'`````G```!4```
M,S````N2`!@``?_8_^``$$I&248``0(!`$@`2```_^X`#D%D;V)E`&2`````
M`?_;`(0`#`@("`D(#`D)#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X.
M#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M_\``$0@`)P!P`P$B``(1`0,1`?_=``0`!__$`3\```$%`0$!`0$!````````
M``,``0($!08'"`D*"P$``04!`0$!`0$``````````0`"`P0%!@<("0H+$``!
M!`$#`@0"!0<&"`4###,!``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S
M-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("`0($
M!`,$!08'!P8%-0$``A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A<H*2
M0U,58W,T\24&%J*R@P<F-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$
MU.3TI;7%U>7U5F9VAI:FML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\`
M]50LG*Q<2HW95S**AS9:X,;_`)SRUJX/ZT_XP\BO(MP.B$5MI<66YK@'$N:8
M<W&8[=7L;&WUK&V>I_@F?X5X^D?4#J/5BWJ/UDR;FEX!;2YQ?D1^;ZUMV]N/
M_P`2QO\`VS8K`Y?AB)Y9<`.P^:9^C`<]R,,<>,C<[0C]7H<W_&%]5L0$#)=D
MO!C;0QSI^%K_`$Z/_!55;]>\S+@])Z#F9=;N+'_HF_Y[67U_]-:+^F_5GZK=
M/NZDW#KJ9BMWFW;ZEQ,[6,9==OLW66%K&?I-BS\;"^N77*AG9/4OV+3=[\?"
MQZP][6'Z'VBZS8_U-OYG_0H_FD8C#5\/IVXLDNO]S$HG+=<7JWX8#_NLC/\`
M:G^,&]WZ'H^+BM/!OO#X_K>@]KD39_C%L$FWI5$]FMO<1_GJUTKHG6\'-;?D
M]:LZACEKFOQ[:FM&OT'L>USMKV.6T7L#@PN`<[Z+2=3\$R4P#48P/E&7_J1=
M&!(N1F#XD?\`<O-C`^O[OI=4PF>3:''_`*HA2&!]>Q_WJX;O(XQ_@]=(L#ZW
M6=0KZ4[J72;W-R.FO%UE3'2RRMI!R*;V?1_F_P!)_I$HS,I"-0%Z?)%,HB()
MN1K^LP%/U_9QD]+M_KUWM_\`/;UD==LZ_P!1MQ/JSU,XWKYUHNM;@N>`<6@.
MMM;:[)C8_(N;LH_XI=EA9E&=ATYM#IIR*VVL/\EPW>Y<U]5GMZEU3JGUJO<&
MT6O^QX#G$@#'J(W6#?\`FWVAO_7?53H2(XI&,1P;4*_6?HK9QN@)$\7<_H?I
M-BKK_6L*IC,OZM9%%+&AK6X5E.2&M`AK&U5&EWM_J*=?UZ^KV\59EEO3;R8]
M+-I?2?F\M=3_`."K<=DX[`2^UC0UN\DN`AA_PG]3^4DYF-ET[7M9?2_D$![#
M_P!4URCXH'YH5_=)_P"[XU]2&TK_`+P_[WA5C96+EU"[%N9?4>+*G![3_;87
M-15S=WU/^K^3:_)Z18[IF8W0W]/L]."1]"RAA]'9^\S8Q"HZUUOH>=3@?639
MDX>4\58G5ZF[!O)]E6=2/92]_P"^SV?\;^FMI/M@_(;/[DAPS_P?WE<9'S#3
M]X:Q?__0%U7H&5]5NMT9UU+K^E4Y++J[FC</3:]K_1N_T=[&^UOJ?H[UZGA9
MN)GXM>7AVMOQ[1N98TR"/^^N;^>QWT$9S6N:6N`+2((.H(*R/^;'3Z+G9/2W
M6=*O>9><0AM;S&W]+A6MMPG_`-;T/5_X13SRC*!QZ2CIQ?HR_O,./%[1EP:Q
MD;X>H_NM+_&'CW7?5FU]32]N-;5?;6)]U;'?I./W9]1RO9S<_K.#BW]"ZFW"
MHM_2NR&U-N<]I'LK:RW:UGN_G?\`"?F*S77U1K#5E''S*W#:YP:ZDD<$.J<<
MJNS=_7J6(/J7=BV/?T+J>3T>FPES\0!MU(<8EU5;W?H^$(F/"(F0!B28R(XX
M>K]Z/_H*2#9(B3Q`"0OAEZ?ZSG9N?]9>@=6;1D]5_:=;L'+R@Q]%=0W45OLK
M;^BW/_G&?Z15;.D?5JCHF'U+KE>5U;J?5VBPWT%[[@Y]?K%U3&V,J95BM]G_
M`'S9^C6[B?5'J#>KXW4^H]6/4CC,LK%5M#6@LM:YEC)99_+_`#F/3,^IW4,'
M=3T3K=_3\$N+F8CJV7MKDEQ92^X[V5[G?14ON0%5,`T.*4`<8E\WI],?^X8^
M"9NXDZGA$B)\/^-)PL;-ZMU3`Z3T#,R+\?'SLK)ILRK6FK(NQ<=C+:JW;R??
MD>K]GL_G/YK_``OZ7U;OUC^KW2_JU@#KG16?8[\5[&VTE[WUY-5CV56XM]=S
MW[MS7?Z^Q]>L[ZJ9.;@NQ.L]2LSK&6-OP\ME;<>^BQOYU=E3G-?_`&F?^B_2
MA1]3[[<JB_K?5;^K5XCA9CX[VMKJ#V_0LN967>N]G\I+W86")<,0290B)<.6
M_P"7!ZT^W*J,;)KAD2/U;S]W4,CHG2^J?5&B3F'(;C])!.KL?-.YL'V_S&ZU
MC[?]-8Q6>A?5SIG5<W-P^H!U^'T-S<'#P2XL:W:T.OSK&5%FZW-NWV[O^K_1
M>GU&7T#$RNN8?6K#^FPJWUAD2';OYISO_"^^_9_QW_!JKU3ZKG)Z@>J],SK>
ME=0>T,NMJ`>RUK1M;Z^/9['O8WZ#D/>B10/!*0XI3_UG\O\`IJ]J5V1Q")H1
M_J.)A="P>D?7VG#Q9.)=@VO;CO)>*VN?M?2W?N_06.;OVN_X14.LOL^K>??]
M7>F9M>-T_JY8\[IG!]5WIW[(]C*;V?S?^B_X'^D6]#@?4V[`ZFWJ[.I/R<]U
M=C,BS*9Z@>7AHJ>QM=E+JF4[&_HM[_9[/T2LX'U1PZL//IZE8>I9/57$YV38
MT-+A_@F55@N]!F/_`('9_-O_`.M^F?>@""9<?IC$BOFD#\_J_=0,<JH1X/43
MO^C^[I^\Z72NE872,"K`P:Q714('$N/YUEA$;K'_`)ZI_6#$_;&-^QV,+J[G
MUG*OX;576]ES@UWY^3;L].MC/YK?ZUOYGK%Z/T5W3<.K%LS<C-90T-K%I:T`
M#Z+?T+*WO;M_T]ERMY=N74UIQ:!D$SN:7BN--/<6N4%U.P>(W8D=-?WM68BX
M410JB/F?_]'U5)?*J22GZJ27RJDDI^H>I77T=.RK\9CK+ZJ;'TUL;N<YX:36
MQC/SW.>N=LO^M[675V.<VW&J<=]%;;&VNHHJ>[TO5HKWVYV5F?HZV,_[0V4U
M_P"%7@"2GP\%>KA_POP8<W%>G%_@W]=GZ#LR_K/L?LKO-]XVU,;7614Z]SK]
M7V^A2[]DX%-;&/?=Z&7U')LIW_Z&N_/^L]M59><K&=96(%.,U[C=7CT/]/\`
M2T6U4MRL_+M8]^3Z-'ZA^COI_2+P1)2Q]KKP?\W?_"8Y>[TXM_ZVW^"_1/3,
MGZP6]3R1DAX:*G;*W5[,=EK176VL.?5ZE_JV^M?3D8^=D?J_Z/)Q\6[T5`==
M^L1;18WI;R;&&UV,:WM=M].UU=9R=[J:+_7QG;ZK&?0R\*K^=]9?/*2;^JLW
MP["O\7U?+_Z.N_6T*N[-_P",_1#^K=>+"VNC>X4.>RP8U]8M>?58QC6V[_L#
ML=[*=[<OUOM;+?4J]%0MZM]9Z6/#,)MNXM]![J[20)R]OVD5?3LN9BX>^RNN
MBO$?G?I:_P!%^D^>DDOU/A7CO_+^7\VM_7?6OH_3'2LSJ.3D9C,VCT64O#:"
M&/:US9?_`(6[:Z]S=K-[ZZ*J/]#9D,_2+27RJDH,G#Q'AVT_)GQ\7".+?7\W
M_]DX0DE-!`8```````<`"`$!``$!`/_B#%A)0T-?4%)/1DE,10`!`0``#$A,
M:6YO`A```&UN=')21T(@6%E:(`?.``(`"0`&`#$``&%C<W!-4T94`````$E%
M0R!S4D="``````````````````#VU@`!`````-,M2%`@(```````````````
M````````````````````````````````````````````````$6-P<G0```%0
M````,V1E<V,```&$````;'=T<'0```'P````%&)K<'0```($````%')865H`
M``(8````%&=865H```(L````%&)865H```)`````%&1M;F0```)4````<&1M
M9&0```+$````B'9U960```-,````AG9I97<```/4````)&QU;6D```/X````
M%&UE87,```0,````)'1E8V@```0P````#')44D,```0\```(#&=44D,```0\
M```(#&)44D,```0\```(#'1E>'0`````0V]P>7)I9VAT("AC*2`Q.3DX($AE
M=VQE='0M4&%C:V%R9"!#;VUP86YY``!D97-C`````````!)S4D="($E%0S8Q
M.38V+3(N,0``````````````$G-21T(@245#-C$Y-C8M,BXQ````````````
M``````````````````````````````````````````````````````!865H@
M````````\U$``0````$6S%A96B``````````````````````6%E:(```````
M`&^B```X]0```Y!865H@````````8ID``+>%```8VEA96B`````````DH```
M#X0``+;/9&5S8P`````````6245#(&AT='`Z+R]W=W<N:65C+F-H````````
M```````6245#(&AT='`Z+R]W=W<N:65C+F-H````````````````````````
M`````````````````````````````````````&1E<V,`````````+DE%0R`V
M,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@``````
M````````+DE%0R`V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E
M("T@<U)'0@````````````````````````````!D97-C`````````"Q2969E
M<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ````````
M```````L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V
M+3(N,0``````````````````````````````````=FEE=P``````$Z3^`!1?
M+@`0SQ0``^W,``03"P`#7)X````!6%E:(```````3`E6`%````!7'^=M96%S
M``````````$````````````````````````"CP````)S:6<@`````$-25"!C
M=7)V````````!``````%``H`#P`4`!D`'@`C`"@`+0`R`#<`.P!``$4`2@!/
M`%0`60!>`&,`:`!M`'(`=P!\`($`A@"+`)``E0":`)\`I`"I`*X`L@"W`+P`
MP0#&`,L`T`#5`-L`X`#E`.L`\`#V`/L!`0$'`0T!$P$9`1\!)0$K`3(!.`$^
M`44!3`%2`5D!8`%G`6X!=0%\`8,!BP&2`9H!H0&I`;$!N0'!`<D!T0'9`>$!
MZ0'R`?H"`P(,`A0"'0(F`B\".`)!`DL"5`)=`F<"<0)Z`H0"C@*8`J("K`*V
M`L$"RP+5`N`"ZP+U`P`#"P,6`R$#+0,X`T,#3P-:`V8#<@-^`XH#E@.B`ZX#
MN@/'`],#X`/L`_D$!@03!"`$+00[!$@$501C!'$$?@2,!)H$J`2V!,0$TP3A
M!/`$_@4-!1P%*P4Z!4D%6`5G!7<%A@66!:8%M07%!=4%Y07V!@8&%@8G!C<&
M2`99!FH&>P:,!IT&KP;`!M$&XP;U!P<'&0<K!ST'3P=A!W0'A@>9!ZP'OP?2
M!^4'^`@+"!\(,@A&"%H(;@B"")8(J@B^"-((YPC["1`))0DZ"4\)9`EY"8\)
MI`FZ"<\)Y0G["A$*)PH]"E0*:@J!"I@*K@K%"MP*\PL+"R(+.0M1"VD+@`N8
M"[`+R`OA"_D,$@PJ#$,,7`QU#(X,IPS`#-D,\PT-#28-0`U:#70-C@VI#<,-
MW@WX#A,.+@Y)#F0.?PZ;#K8.T@[N#PD/)0]!#UX/>@^6#[,/SP_L$`D0)A!#
M$&$0?A";$+D0UQ#U$1,1,1%/$6T1C!&J$<D1Z!('$B8211)D$H02HQ+#$N,3
M`Q,C$T,38Q.#$Z03Q1/E%`84)Q1)%&H4BQ2M%,X4\!42%3055A5X%9L5O17@
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M-NDW)#=@-YPWUS@4.%`XC#C(.04Y0CE_.;PY^3HV.G0ZLCKO.RT[:SNJ.^@\
M)SQE/*0\XSTB/6$]H3W@/B`^8#Z@/N`_(3]A/Z(_XD`C0&1`ID#G02E!:D&L
M0>Y",$)R0K5"]T,Z0WU#P$0#1$=$BD3.11)%546:1=Y&(D9G1JM&\$<U1WM'
MP$@%2$M(D4C721U)8TFI2?!*-TI]2L1+#$M32YI+XDPJ3'),NDT"34I-DTW<
M3B5.;DZW3P!/24^33]U0)U!Q4+M1!E%049M1YE(Q4GQ2QU,34U]3JE/V5$)4
MCU3;52A5=57"5@]67%:I5O=71%>25^!8+UA]6,M9&EEI6;A:!UI66J9:]5M%
M6Y5;Y5PU7(9<UETG77A=R5X:7FQ>O5\/7V%?LV`%8%=@JF#\84]AHF'U8DEB
MG&+P8T-CEV/K9$!DE&3I93UEDF7G9CUFDF;H9SUGDV?I:#]HEFCL:4-IFFGQ
M:DAJGVKW:T]KIVO_;%=LKVT(;6!MN6X2;FMNQ&\>;WAOT7`K<(9PX'$Z<95Q
M\')+<J9S`7-=<[AT%'1P=,QU*'6%=>%V/G:;=OAW5G>S>!%X;GC,>2IYB7GG
M>D9ZI7L$>V-[PGPA?(%\X7U!?:%^`7YB?L)_(W^$?^6`1X"H@0J!:X'-@C""
MDH+T@U>#NH0=A("$XX5'A:N&#H9RAM>'.X>?B`2(:8C.B3.)F8G^BF2*RHLP
MBY:+_(QCC,J-,8V8C?^.9H[.CS:/GI`&D&Z0UI$_D:B2$9)ZDN.339.VE""4
MBI3TE5^5R98TEI^7"I=UE^"83)BXF229D)G\FFB:U9M"FZ^<')R)G/>=9)W2
MGD">KI\=GXN?^J!IH-BA1Z&VHB:BEJ,&HW:CYJ16I,>E.*6IIAJFBZ;]IVZG
MX*A2J,2I-ZFIJARJCZL"JW6KZ:Q<K-"M1*VXKBVNH:\6KXNP`+!UL.JQ8+'6
MLDNRPK,XLZZT);2<M1.UBK8!MGFV\+=HM^"X6;C1N4JYPKH[NK6[+KNGO"&\
MF[T5O8^^"KZ$OO^_>K_UP'#`[,%GP>/"7\+;PUC#U,11Q,[%2\7(QD;&P\=!
MQ[_(/<B\R3K)N<HXRK?+-LNVS#7,M<TUS;7.-LZVSS?/N-`YT+K1/-&^TC_2
MP=-$T\;42=3+U4[5T=95UMC77-?@V&38Z-ELV?':=MK[VX#<!=R*W1#=EMX<
MWJ+?*=^OX#;@O>%$X<SB4^+;XV/CZ^1SY/SEA.8-YI;G'^>IZ#+HO.E&Z=#J
M6^KEZW#K^^R&[1'MG.XH[K3O0._,\%CPY?%R\?_RC/,9\Z?T-/3"]5#UWO9M
M]OOWBO@9^*CY./G'^E?ZY_MW_`?\F/TI_;K^2_[<_VW____N`"%!9&]B90!D
M0`````$#`!`#`@,&````````````````_]L`A``!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`@("`@("`@("`@(#`P,#`P,#
M`P,#`0$!`0$!`0$!`0$"`@$"`@,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P/_P@`1"`!$`,$#`1$``A$!`Q$!_\0`
M]P```04!`0$!`0$```````````8'"`D*!0,$`@$+`0`!!0$!`0$`````````
M````!`4&!P@#`0()$```!00!`@8"`@,!```````$!08'"`$"`PD`%@H0$Q05
M%Q@@$C`9$3$:-Q$```8!`@0$!`,$!@@'`0```0(#!`4&!Q$(`!(3%"$5%A<Q
M(A@)02,D$%%A)2`P,E(X&8%"--26UB>7<9%B@D.5-]<2``(!`@,%!`4%"0L,
M`P````$"`Q$$$A,%`"$Q%`9!42(587$R(P<0@;%2%B"1H4)B<C.3-C#1DJ+2
M0U-C)#24P8)S@Z.SP]-4-287XZ3D_]H`#`,!`0(1`Q$```#?P````'Q??Q%J
M51.(\OAT=)'&F5?&%`.#?\GUY]OQ]='GT4B54\S0\Q?D\6FE"9S=Q1]Z]?CV
M``````\O?*L[5J:C:\:)@M/:_=QH>9W0.?3N@5@2ZB,PD5&I,[C2\*9*J]?/
M?/WQ-*4S3NS1D=UYCJ\JC;WA+-X*G5*?G=.5B]<65;[3ES]+GU`K`M&JL/NW
ML+/.SO>LS)NN;<ZAN/)UK;('!4)_I\-7.2M?+Q`X``?#TYY%]?8XU[8]V77E
M8E<5TV/6FB/.FD@`//WRL>T*KHYO6A;6JEMVZBD[R_RFOU6_)JW2I+>WU8&_
M07W^?JD&\:)<UK=)MP>=HE:A5:95G1T?FFS&L;2DI&9111?%`MLYM>D7-6G,
M].B,XR!8)"S3PS605M9B:5)%DB7635I9\C(W)<I>L<C1Y>F-#.;8V3FV;O\`
M!V^_Z%!E_9[FA"IQ"B;P6G.XJ93RI+JIRIK+&ULS%5E=:6=KPQ_LG&]LW%/8
MX=X2S>"Z!,]Z*GW7]AU!7'3"44I8^R"/;%L<;0_(5>6I5$\:_L)U&MUISN:E
M8SRF)V0UG:$V(/.\=6R\5RIBDLKKL6N)?PV:(QP;EZWN'6X*%,F4_3\=&@=V
M:]BB+]SH:0S0H$JJ1D<DL:)/%U$E5:,LX:5E]#IHIDJKV\]```2RI(QC\PO0
MR/:25I./VXNHU.J55)4JK2.VTNZ/6(W.:W3D]N/6X]N'WX<GKQ0R]`OF]P5*
M57Z>>@10E<2K\G]?794K=P``````%:-G5;%^5Q)4I%CD-3LC%[>R;XQ*](LL
MSJ^TV8>F3]>>M.[M"W;U_K\_3WLKY*R)2\`````````"I6W:>K%M6IOF\][J
M93'"3Q;M\^O=1K9N0>=5\3^OEEP[."@<%<D605G,#MLJ"X[[Z`T*`!__V@`(
M`0(``04`_''CR9KR]`K<TX$8MT1?`\;7%S<#Q<5V2E(LFUM*Q@R6\K&2G*QA
M%W<RQ=5'^!$9G&P\9YI34F<-V*K=<*+.'$!LGYVVW77)IE7#4UI'%\NQTO;Q
MD4+C%/LU":L-)2C\E1\B7*&4%NZY8W@A7*L77*/'9JUNNN\*5K3F,<-P\P*Q
M4A>#C`<W;($K_.*1A,$EQ(RRBRCNJ*?"C9JVBD85Q$]3-AS!\O@V[5'SB"D<
MUZ-1&-?/,E$->JGV7REK=<)&B$NT*,09#<_+6`*VO^V6>II4'<9^.++DPY#8
M*!=9D>-4E.L5Q)!5^[JWQMNK;5+O&X"5J!<5JW;L<YEC=!V\39*`3A"^[A#D
M607777W<CXG\!VX;V*X6J%V7(Q7&X2K=+ZE$HCCY9'?U[0Y5:Y+*G2#"MXVA
M^XH_Z]H&N5LR`]:5<N2E+D8LV,`A42@")BQA\'I'A)&UCA-XDFZ5[ELX$3)`
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M??:!CTW+?*HK>-(J!$84P+]10/GNNNON_`&.&EV?.KSD=S/G"9J8%"?A<?5*
MGX+&C!^8(=G(#'U2I^"A8H;F][.O3<P"!`:[@84)!Y1AB8&-UBE4>.T88#S'
M)2M;:^!.I`Y67_,-G\*(;L4LDZ):4N*@1NV1(2F&)O`652#6S*P9V-:Y%^[9
MFT2X)'$Z-/CX!A;,_$8,S8*O"7!&F/+#K*UZAN*Q#4K#`&5"-,TG=_&']7\*
M+_U_L2^]5Y)?UI[:HO4?HNO2^L'=.^PM![WT47?^;'/M?6-O2/OISZSSUOZG
MS7S\W]?'_]H`"`$#``$%`/QR9<>&PQ<!#%-!C\M4#H(DRV^'@B5:/QUNE<3W
M5I*;'=RDHJ\I*4';S%*E*_Y#R?;;-QYG?*3IN&CM0R$3F`0'%8_SNNMMM4[W
M-RE[CZ5!EDK8XSYKW($8-VU/>512+\=`$<&R!U!L\V(&H='I()3$7@,%*6TM
M\*TI7F0"!S<$)%*"^`"XO<=]#R/;;'HL1&$,#OJBY')7GS@Z"0JF9`-NHZX<
MV$3B\'+=D@;@*M'36BZR-\RBM7=B381ODQ2VT,"#JEXUJOC^U@'7,*71Z='!
M0IH-M*_'+BQY\12+,&E?/CL*WHM"1H2/LZ0\;K;;K52R[>*R@YMG8:#(UKW$
MR_NXI3P>I5`P3=`5LH;++<=O)$J$01-RQR/")5`F2U1Y.+HY#?5JK5H0(HBK
M(I=&US9O>1K\4XSGI]MR_P"Q3@^2Z"@('>0C9*VU:HE^!XI<N$?OR#(!/V-5
MY1>W;C*]R$:V#SC%0H'=>&Y`94ID56<HY(9`!RG']D%AQ[69,R<SCNX!:E#_
M`,)+$V<S;MGU&&4S>&L<TL?G+R,PF&]2RCPW*H_6:T3+4)U>N&FU*ML)>&7L
MD_TL_0Q(BU*R%:)14:I3)BTW'I^.28*BI`.:F2I4HJ*EW[)21R1``<3`DX=;
MJWG^N*XLO<SGL1+X+9AT.L;R0N>IKK"5TTD:YAH,&:`3!,.,PA\%E>1UQ.V^
M!&XR94Z!-E,V]S_I8ZP!7X9L()<TA/B=3_:XI]O9](JE5K23R-R4'D#;EP%L
M$TME='X8LWS.7(+XRG)25HVRX?(MRG$29JRZQ3JYS*D'Z>HD/;;;9;^`T`!,
M<&!'$H"N`.,PUSIQ/"LG2B7X$!`B_"+(R0PR]*)?@4(%`X/8R3U/,X<.)MX)
M"A1F($6EQ;9>F4WDN!%Y>6XJTI6G@=)H2:F'PU?_``KIQPB+485WC(V&D[H'
MAX797&'8DR!<\U&D0)U5O[1A<Y5#5F<K4@(##,YZ>#9\+I)/,9"W=(;R3$Z:
M<M-0[LHT0*2RT*U=;_&(]'\X-]Z#WYOO2><8]$>YIOT_[H/U?HP/4G4#R>Q]
M;F7^?DPE]UZ,NZP]A)O1^0A?2^4P_E?OX__:``@!`0`!!0#\3`R+BD(NYY0I
M;.]8[R=82-N47<@Z[R6IIW/,4L=1W=%-+9?C[G0M%4Q]S#=6N'N:D9@X6]SY
M%V^].]R/K^.*;A-KS8.SKZU2X82P=CR2*`A4H'\\V;"&PR3W.Z^HS97S[H5<
M#KP>PG=Q.<R2^BK:W)3,VO:YH+!B0O;OZV4EC2NIC6^C<:>B+%%)6EJ#0Q-;
MBPX<-O,F+%EH8H=%'%I_$R+"KM0K>H38-NS>/0SKV>95'O;;)]'B[X>=P9&.
MO]T&R:*.2.6]G7O(#*3G!0H2OPV-[4&'UXI:96U"8LW!\"M+DK9QAHL:,(#Q
MJP8<"<1I!)K;C,F<K[@M%>T1<X:Z&ME)!5K,2RP-AXF987G1:UZR7NK3=9S:
M=*NR'L(NW*BG>TD4/'-APB,,F]/<!I28%QKSVC:GQNL[<TT4ZL_)./DNY)/Y
MH7UZHB9#[!0H4"%YW`S_`)XR.OC2G$I(QA@LX\S8C,^J<.Q>`HC-*F83%PZ9
M._N!IIN@*UR;GV6G8IM@FR1A]>*#_P"@>=5I5LK?1D-L,(=;TI@\QH:;P5VI
MIJS[>_>&C&'/,W<*RM:;)`'81*O8E$36YN!54DGWVN;:LL$S6+XZ3ATU?-^\
M%2!K`'_19+OFZ?3@X;8N)V^,\$'%Q]:5I6G.XU:`\<>`6I*027D5K_=3M[XT
M/Z[6WO3G&Z`<9WW*Q$GGJEY,"..KF/LY)^1_D7,\J;]/3C[B.H0+4*X#&-U&
M7?=JFD'9K`D;&["ZJW8GMZHZ-FW$$MDL<FRDO#7M@K?TBYW#45$.B"C0XU!#
M-247+KK;+90(`3L:R?!C,^$S-'\+)<"F3;K<#K7!-'LRBPY!NLD>D7-12\C7
ML&T:O>D^Z%9X03;7]RK1[!8W21@>[$A]=PC>G'%X2!(;K=1Z:5&QYC7Q:F1]
M>Z$;3X]U-1,DW)V8O<IPU,ARW8C7JA$1K:CK,.5VB!8S)W5O-L(0';=.BW#7
M0_LQK[N`-B<_(KN7IYEJPLU#N2J5N(,BB(0X?`$P?@L$,B7#)2*(S.(:XE(E
M<47GD>&`4YC]5XP\2:,1Z")U:R3,+\Q^J\8>)E*IA%DWPFS-%+PY(")1!^*)
M,)I7E2.;IOF["C(U1S,<Z.0"$;LMRXL6:SP>.-JA=!P?Z<!?\,T]A*6A[(5/
M[5W!==4M!L@?)Y&[%;!%F'CHB]D3GKMDT%LSF>.;(DV+R?6DNG7ERRC)KDTV
M1L22'Q=LOB\8.$J]KK%9F<+-G,?`[DD.U.'QXH8RS!;:5@3^,^Z8_N>@UT-\
MW07Z8]W</Z7]:L7TAY<*.O?8D;\\?-NW+X5^X[@^7_8\POR9]0L?VV^"&FZ3
M]CA%T7Y.D+R/=/'_V@`(`0("!C\`^Y$<4;-(>``))^8;#D.D]1D4\"()`O\`
M"*A?P[#_`,8:)3VRRP)^`R8OP;`RR:=%^=.2?]G&^P,_4&GIZA.__"&WONL+
M5?\`42GZ67;Q]?6H_P!0?\LXVW?$.S_4_P#SG;W/7=BQ_P!&P^B1MCRO4NG2
M>L3+]$;;$Q2Z=*/1,ZG^/$OT[74G55I#BTNW24*'25,ZXQ+!B*DJ"J+)*`:,
MI$;4%0=KK7;?0M1EZ3!*V3+#*T+0H2N<F%2OOF#2%^)#`5H%H8KF!XY1V,I4
M_>(!_<`J@EB:`#B3M'/!HIM;)MXEN3DJ1WA6!E8=Q6,@]^R/U'U/++)N\%M&
M$7U9DN-C\T:["36;2PC?OO9S*Y]43-0^I8MLCI_3WF*[@+6UC@3^&XB-/2$.
MSKI'2<*CL:>9Y#\ZQB,?QCLPM[NTM5/]%;H2/GES3^'8B;K.]`_(<1?[L)L3
M==3:A)7ZUQ,WTOM6:]E<_E.Q^D[58DGY*@T.U8;R53Z'8?0=ARW4M_'3ZMQ*
MOT.-I]2U6\EDZPUI!BDD9FE,MS&%6K,2U;>S0`;_``N`-U=K2P@N[66S@C6-
M$>WC`5$4*J@QY;4"@#C7=LL/4_0UA>1'VBI(W?FS+./FJ-L&M]&2Z9.>+QH5
M4'OQ6KBOSP_-LS]`_$11<'>(I&24CT8?<3K\Z.?7M)+%IBW]HM3BM6QM0=IB
M(6;[R,/3M)!<1,DRFC*P*L#W$&A!]!^5I+<BVT&)J2W+@D`\<$2[LR2F_""%
M4$%V6HK&VD:6LFI`;[F8"2<GMPDC#$#W1*OI)._::RDE-]KZ\;>)AX#_`%TI
MJL?I4!Y.]!QVEAM]0&G:<U1EVU4:GY4U3*Q[Z,JGZHVJS/+=2-VU9V8[AWEB
M3N[2=HNK/BU<1FZ-"+=BV7&2*B(HGCN)Z;V1?=IO!#`%MC::9\/BUFNX$06D
M8(]"T<T]9KW[+#=_#MN6<T?W-HWA.YMV$5W=E17O&VHMIPIIYGDRN(]WC.#C
MO]FG'?W_`'$<T3E94(((X@C>"/4=AU!;:?;CJO3`6E:.)$=G@'OP<M02)H&$
MX7AC`H-WR:+I,L>*P1\Z?NR8J,P/YYPQ^MQM;=-VTG]BTR.C`<.8E`9]W#P)
MEQ^@AQW_`'`920P-01V;11VNN/<V*_S-S69*=P+',3T8'6FT>E=?Z''8:XPP
MI.6HM3PP70`>/L\$X:+@"QV?5]/F-[TN2/>@4DAQ'PB91NH=P65?`QW$(2%.
MVD:'IJ*+*V@5013QFE7D-.+2,2Y/:6]6UEINBRF/6M1+@2#VHH4H)&0]DC%@
MB-Q48V%&"D,[L2Y-23O))XDGM)^2UN+J,/#80/<@'>,Q2J15K]5Y`X]*C;5H
M&F)TO3Y7MH$KN&6V&1Z<,4D@9BW'#A7@HV2_TOIF_N+)B0LD<$CH:;C1E4@T
M.XT.X[N.Q/V,U2@'_33?R-H]`T6TK>;RY>JI$BFC/*:>%5)`.XL6(506(&T%
MGU+\1EBU=P/"&MX14\,*3.9&'<3AKW#8:S:WBW_3A(!E5<+Q8CX<U*L,+;@L
MB,R$D`X25!EM],PPZ=#3.N)`<"8N"@#>\C4)5%[!5BHW[>4#XC_^04IEUMJX
MN[(S,SC^+CQ;2]'Z^R3=/ZU&1;S+7*>>$$A"IWI(\9>-XVWDLF$LM#MK>AJA
M%FLF9`>^"3QQ^O"IP'\I3MU3\2]5C%9$81UXF*`T"BO]/<D1^G`NUSUG\2^H
MAIJ7;M.R>!9/>G'BEDE(CA+5)$='<"F(*?#M#?=)=9F^LDD42H)(&)4FC8)H
M@RQR`591)$58C"2M<0TC3-1O;^XZ<N[<2%T,2W$7C9&-#&T<@&'$%HA(-*@B
MIT[J_H[4Y=0Z9E13([82R!Z9<H**H,3UPFJAHWHK>UNU+6M=O9;/IBV!&8N$
M-)(!B;"S@JL<2^*5R"!55&^I6XMNDI+N728V*K+<,F*6F[&J(B!$/XH.)B*%
ML)\(VN/AKU&>:TN:VDY<2>*BA3FVQKQB>/$R`_HRI"[F`7]HV_A#;3^DNI;M
M8-=MT6*&5R`EQ&H"HI8[EG50%HQI*`"#CJ#8ZUI$#2ZGIF86B`JSP/A+E%XL
M\94-A&\H7I4@`_(;*9PO/6<D25[9%*3*/\X1L!WD@;=1VT\9$%Q</<1,>#Q3
ML9`1WX260]S*P[-M&T+2-(L!86=I%"#*LC.Q10&<E9448FJ0`NX<234FYT76
M+*SCMDLWF#0K(K8D>-0"6D<4(<UW5J!OV^.O66G0(=835[X*:5H(*&,$?562
M9I".!H*\-KZWM;Q&OL#3SSSNQ%,06K$!W9F9@``#Z:`;=1](]7ZG;WNCRP2"
M$(9#E(T;B5"9$2B`X9(P-R,&.ZNVCW/3[F*_U%E$DJ;F4W#2EV##>&RXEA5A
MO4;P00#MF8CCK6M=]>^O?Z=KC7=3N&.N:/.)()VWOF6DL3128CO+X)#"S<6X
MDDDG;H#KCIV`&^N7BMY%&_"+A\(#4[+>XS$8]@>IW#;X4?".U(.GB5)YE^M%
M9H[0(X[1--&TC@\2HKQVO-"GF<:7IZQB..OA+R1K(\I':S%\(8\%4`4WUT&]
MTV5@)+F.*5`3AEBD<*Z,.!J#5:^RX5AO`VZ;7NT]O]_+MJ'PZU*Q:\Z>F@E<
M5&)8`125)*[LF:M*=DI!4>-B-"Z!Z9TU[7IZXC8/*OLLB-4VX:I8L['-G9C5
MPRBK!G^2@X[7'4LY#=7O`\=G;\3;YJX6NKGZA5"1!`?&[-F2!(PN9_W6X_6-
M^_\`)!9RW`U#2$H!%<$EE`[(YA[Q*=@)=!V)L]\\\W3754AJS-'F6DKG>3)E
M<"3QD"Q$\65SL]]96\6IZ.-XN;&1;J*G>V762/=QS42FUM?V4S17T$BNC#<R
M.AJI'I!'[^UEHW5TD=CU?"**<2QMC(\3VSOX'20BKVS[P?9K0/LW(=56KVQX
M&2&5&IV5"YB_.&IM<:Y?:M;W$+VCPX8TE#`L\;!O&H%`$(/;O&WQ-Z*ZQ58^
MG]3U*X.*4$(CNS(PEKO$4\1`Q\%*HU0I+#5)_AUUM'!I5\@&)LP3"(,'"+/`
M'#J6`JZX"P`!%*UGMIOB-G1.I4QO<WI5P1[+8D*T/`U%._=MJWP3^(C<K>0S
M21PEV";Q(6P*[>%9H9JM'B\,BM@WTHW[5P>3UKCR9,[#^9^CK3MS</;PW;6O
MPFZ*N%E12HN9%8.%"OF,K.OA>:66CRX?"BK@W5PKKO2%_<!5MPUW$6.Y8J`7
M(]`2BR^HR':7KZS/O(KQ7@4UH(8B%CC/<&C%'IVLQXG:SZLZ3UI+;J!8E26-
MQB(`X1W$:G&KQ[U290R2)3<0`1;]6]=]1VK<M(IA7?'"):T1V:7"TC*Q!2-4
M'BHQ)`IMT?::?ITTUS/9%(U1&8N^>_A6@WD!@3W`@G=OVP$1OU]J8]!]X!Q]
M,%H&W=DDS?5;PW_P]ZWGKKT49>*8TQR!:X9U)I[^"M)!_.Q$DU]X1/:ZIU7I
MLC(Q`6UD-S(:</"BA$)[5EE0CNV,M@SI3@QIB]8('A/=0U'8W;LSNQ+$U).\
MDGM/W*W.GWDL%R.#QNR,/4RD$??V`U=H;[=3%<1)))^NH)_]IM5+$1/^0[%?
MO/C/\;98;;7+R.(<%6:10/4`P&W[1W_^(E_E[&XOKN6:X(`Q2,SM0;@,3$F@
M[-^[;)L=7NH(?JQRR(/O*P&W[1W_`/B)?Y>SW-Y<R37#<6=BS'ULQ)/SG;D_
M-[KDZ4P9LF"G=AQ8:>BGR,]M.\;LK*2K%2584920156!(8<"#0[OD6>TN)(I
MQP9&*L/45(.ROJ%_-.XX&1V<CU%B:;1K'K]ZJH**!/*`HI2@HVX4W4'9NV6;
M4+V:>8"@:1V<@<:`L2:5)W<-JJ:'Y9+"?2([A6=R<1`%'3+8;D+5"UPMB\!.
M):'C^Q.F?JX_^5^X]8:K96US/J-B+=;>*'![V69R'QXA[,<2LYPD&M-_9M,V
MLW-Y%J-ITW)J-U'[L".X:<PVMN*J:!Z5DJ2WU2-NM+J\U&Y'2^F6-M)$_@$L
M]U>P1R6\`.#!2K.\A"U6)*\37;2M`EO)88;;3$O-5F;"1;*4SY%04'B2)X85
M5BQ:Y8KPW#XE6[7USY-HVFBY@<X`\KSB'E%D\.&CF7Q80":>$C;6>C+#6-2'
M6=EIAN6,BPFT:2.V6XEAJN&5*`E0QJ`10U/&PUR[FU9Q<::+CGH$CFL(;AE)
M6TFCC5ID(8")Y'=`KFN'#4;0ZCI=NLL4FHPV2J&&,SSJS1C#QPD*U7]D4-=M
M0EM[W3I)8!<L(UNHFEE2TQ">2)`22BX6PLV#,"DQAA0F.^,5NUTT<$AM5GC-
MXL=RRK`[6]<8$A=*#>X#*650:[:/87SVUQ;RWC03K:W=NTD+Q(TLT4C$E(I%
MC1SB8-&"I!8D4VGUN`VJV7EYOTB>XBYHV>(C-RA1CA%"QHH-1AJ33:*86T$E
MV7MTDMTFC:X@-TP6WSXJUCS695%352P#A:[0KJ%U9REI)(R()TE,<L1`DCD4
M4=&6HH2N!M^!FH?W2;R[V/M&O,8<6/\`NAR>&[+]OTX]OB?D9>5R&@8,..OE
M^`8,-?Z[]+B[>&WP9^T.3]DJV7.Y5<6?DV].9Q=O*8<O^KS:=FW7_P!E^6^W
MGGS^9YF3BY>KY.7S7N.6S<5:^+%ET\.';J#S/EO,\73'F-*TRZ[Z8?!3,P9F
M'PTPX/#3;XD_8;D?MWES>98^:YKEZCF.3SO<8,.',R_%E>SNIMUY]B^3^V7D
MQ\QY;.\KR<$?,<IA_L_,8?K>''F9?BKM\1O)<CS&D/*X\69S.3=8N7INYCEL
M[+KOQ4IOV?R7%S?V1ES,G'R=:^\K@\/F.#'S&?O_`*+=MHWE7EW_`+8\QTKF
M<[/RL>&+!R5?#ETR^:Q>/#^@W5VUC[`\OYEY=K6+,SN<YOESC]OP\OEYO*X?
M%CQ9WBIM\0?+\G']DM*Y6F+^X_V/'@KV\,S%X?;VA\QYC#YI:^99_F?(4J*\
MCD^'E\_#P]]G963X:[=&8N8RN7GP<[7S3#FBG.8O%ETIRN+Q8,>+Q5^X_]H`
M"`$#`@8_`/N3)+(JQCB20`/G.[8^8=7:=$P[#<1%OX(8M^#8_P#E*RL.R*&>
M3\(CP_AV.5'J4WYMN!_O)$V(@Z>U%_SC`G_%;:D'1EVWKGB'T*VWN_A]=M_K
MQ_D@.V_X<WOZ[_\`.-O?]!7RC_2J?IC78"[Z8U&/U&!OID78"6+48CZ848?Q
M)7/X-K6/I.[GPZK<O$6*/$^3;X6GPA@K$,[1PDK56K(M30C:VT&YU[38>KB`
M]ZK31),)G`;)?$P;W*D1A.`(8TJS5$MM.DD1[58,/O@D?N!9B`H%23P`VD@G
MUP7=\NXQ6HSV![BRD1*>\-(".[9TZ:Z6BA3?22YD+MZ\N+`H]1E;8Q:+>7\B
M=UE`(D'KE5:CUM+\^PGZBU!(`V\FZNI+A_X"&45]!<;(VL=73,W:MO`D8^9I
M&E/\4;`W%I>73#^EN'`/S190_!L#!T58DCM=#*?ORE]@+7I?3HZ?5MH5^A-@
M(;*%!^2BCZ!MN`'R4(!&U)K.)QZ44_2-CS73.GR5^M;PM]*':WTW2;**/HW1
M'.&.-%6$16LA9J*H"@7%XY)W>)#7?3:\OY[.[BO)Y7D=X[B0EG=BS,1*9%J6
M)/"GHV:;I;KO4+*4;UQ*#O\`SH6@;Y]^V/0^M8M4@`W)+(&:@[*72'\$WS[*
MGQ`^'#FV&XS1+)$#Z<7OX&^9T'JVBAEU1M/NVH,-TN6I)[!,"T/WW4^C:.>W
ME62!Q564AE([P14$>D?*D=P#=:_*M8K9"`Q'#,E;?E15!&(@LQ!"*U&(E76-
M5:/3"=UM"3'`!V!@#BE([Y6;T`#=M#?1Q+8=/-PN)E/C%?YB(4:0=S$I&>QS
MPVBFN-..I:DM#FW5'6H[5AH(E'=568?6.U%6.&TC4\**B*-Y[@H`WG@!M+TC
M\(;:06HJ#<J%S)%!H90[^"V@KN5V]X^X@J2$V%WJGQ$"WK;R#<7DI!/87J@K
MZA3NV::S^)"\R@JGOKQ?$-Z[\1IOIOH:=QVTU=2-=1%O'F\/TF`8^&[VJ\-W
M=]Q)#,@:)U((/`@[B#ZQLW3UUJ-RW26J$+$)97=%2<^X(S&(!AG!@+<<LU)-
M?DUO5XI,.H.F3;]^=-X$(_,&*3U(=KGJ:YC_`+;JDE4)XBWB)6/?Q\;F20]X
M*'[@JP!4BA!X$;2R7>A);7[?SUM2%Z]Y"C+?TYB-M+JWP]UV74-!4XG@"U;"
M..9:DE)-U:O;E9>)"KLFCZC"MCU4`?=$UCFP^T8&._$*$M$_C4`D%P&8;:QK
MNINQO;F=V(/X@J0D8KP6)0$`[`O?7:]U/6XA+HFFA&,1]F:9RQC5QVQH$+NO
M!C@4U4L"J(H"`4`&X`#@`.P#Y+JVM92DVH7"6Q(-"(V#22T(^LD90^ASMI%P
ML(&J:C$ES.]/$<Q<425XX8XV50O#$7;BQV>PU7JC3[:^4`M')/$CK45%59@1
M4;Q4;QOX;`#K;2JD_P#50_R]I.H-;NZ66X($HSS.PJJ1+7Q,P!(WA0H+,0H)
M$][TQ\-FFT9#[16XF-!QQ/#&(U/>!BP]YV.BW=FVG]2`$B)FQ)+A'CRGHI++
M0EHW57`!(Q`,1#<:IBFU&>N3;QD8Y,/M,2=T<:U`9V[310S;MO.#\-?_`!VM
M<REU3#WY^5E\/QL&':+K/IY7@ZAT.0&X@:F;';S$`N&7=)&D@21)%W`+)B"M
M4;:'KK.#>-%ESCNGB\$M>[$PQC\EEVZ4^&&DR$K'(F;3@LTXJ6-/Z"V!D]&8
M=K7HGX8].'4Y+1%@5_&T9R@$PPQQ`R3!:`&2J(37"6'BVGL.K^BA87SQ,8G,
M<Z@.!5<<$I5I(R:*S1RAD!Q`-3"=8U33;'3[;J6TN#&$<2M;3>[21142+)$3
MBPEJR`$8J$&@U+H[K/2X=.ZGB=A&B8@KF/\`21$.S$2I3&M&*R)5EIAWZ;HF
M@V,5[U1<D-E-B*QQDX5Q+&0S22OX8D!!-"QW80UM==7QVD6KRJ&:&W5\$5=^
M!G>1R[C\8C"H-0N(#$=K;XG=-#E-5@N8^8,?A!8L!%<BE*2K)A5R/T@8%MZD
MM^S2_P`%MM1ZPZ8M&N-!N':6>)!5[:1B6D8(-[0,Q+U45B)(88*,+_1-8N%B
MTS5,L)*QHB3QX@@=N"I(K%<1W!PE:`DCY%O8$+<C>Q2O3LC8/"Q_S3(I/<`3
MMTU=02`SV]NEM,HXI+`HC(/=B`5QWJZGMVUK7M8UB_-_>W<LS")HE10[$J@#
M1.QPK0$EMY&X`4&UKK>CWU[+<R7J0E9FC9<+QRL2`L2&H*"F\BA.[;X"]%:C
M.XT9]'L"PK2IGJ):'ZS1PK$IXBIIQVL+F[LG6PQK!!!;HM:X2U%!*(JJJDDD
MCN%2=NFNL.C=+N+'68IXS,7$:YKK(AB<"-WJY!>.0FA=2HWTVUFUZA02Z?IJ
ML8X7WHPMTB$:E3N*YLK3,O!CN8$$C;+PC+I2E-U.%*=WHVM]`TNW5="UF`QS
MVZ[DR[R*598\(W!<R,3*O!2:*``!M\0NA.I)RMC:I+<QDFF(VZ8B5KNK<6V6
MZCM*4&\[?%OXP751J)BD@A?ZLMY(BSLA[#!!(L:$<`QIPVL]>@A0ZKJ+R-))
M3Q!(Y7C2$'L50F(J.+L2:[J:_8ZG"IR[:26)R!BBEC1G213Q%"*-3VD+*=Q.
MW4S=^HJ?_KQ;:=\2-,OUL^HH)XHS0X6G(-8GCIOSX:5K^-"&#'P*#KWQ!ZHU
M1+OJ*VE4I$U,2NZT%R5H%"(HRH%484(8T4JGR5/#:WZ8@#+T<EPDE[<<!<")
ML2VEM]<,X!GG'@15RXR\C-E_]IM_U:_O?)/>Q6S:=K#U)EMPH5R>V6$C+>O:
M0$<]K[)8I!#U/TG'N5$DR[N)!N`CS3O`'",O*!P5D&R6-[<RZ7K)W&VOXVM9
M:]RYM(Y-_#*=Z[75A>PK-87$3(ZG>KHX(8'T$'][:]UKH^.2_P"C9C5EPM(N
M`'PI<HGC22,&B7*"A'M$5*;*+_I.Z2Y`\0CFB=:]M"^6WS%=K;0K#2+FVGCO
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MX).*XZ/Z!Z:NEYI&69]TDS14JZ*L6)8U900\C.?"2H`)KMUG=ZAJ4$%M!?"2
M1G=5")D(`S5(H"58#O((&\4VQ@R1_#[2SZ1[LG\$]V5W]L4"_6'BT_XB]#6]
M.GY9`DL"@X(RU,<#@5I!.!6,_P`U,`!3W8-O=Z5TEJ<:.H):ZC6VC%>/B=B[
M@=C11.#QKME7ZH]?:45P'T$$^(=]10]J]FRHB@(!0`;@`.``^Y:VU"RBGMCQ
M21%=3ZU8$'[VQ.CK-85-<-O*\<?ZBI@_V6U'OS*GY:*&^^F!?XFS37.@V4DQ
MXLT$3$^LE2=OV;L/\/#_`"-A;6%I%!;@DA8T5%J=Y.%0!4]N[?MG7^CVL\WU
MI(HW;[[*3M^S=A_AX?Y&R6UE;1PVR\$10BBN_<J@`;^X;<[Y/:\Y6N9E1XZ]
M^+#BKZ:_(J7,"2(K*P#*&`93B5@"#1E(!4\014;_`)&M[RVCE@/%74,I]88$
M;-'IUA#`AXB-%0'UA0-I6DZ>L69S5B8(B6-:U:J;S7?4]N_9H=.L8;>$M4K&
MBHI/"I"@"M`-_':A%1\L=_!K$ELRH@&$$[T?,4[W"T+4Q+A\8&%JCA^V^I_K
M)?\`G?N/1NDWUS:P:;?&X:XEFQ^ZBAC!3!A/MR2LJ#$"*5W=NT*Z);6<NFW?
M4T>FVDGO"9+=;<37=P:,*E.$=`%I[0.W1-I9:=:_:G5+^ZCE3QF*"ULIY([F
M<C'CJ`J)&"U&F>G`4VU;J"&RBFFN=4DL])A7$#=,'R(V<U/A>5)IF90H6V7%
MQWGX97*V-MYUK6IM;3H,9CB2`S<V\?BQ500^'&2!7Q`[:+UK?Z-IC=$WNIBV
M41M,MVL4ERUM%/1L43U(#%10D'=3LU#0K2'2$-MJ9M^0G>2&_FMU8*UY#)(R
MP."I,J1(CED%,6+:;3=5N6BFCTV:^9BIP"W@95D.+AB!9:)[1J*5VT^*XLM2
MCAN#:J96M95BB>\P\O'*Y`I(^-<2J'RRP$A4U`DL!+<K:K)/&+MH)!9O);*S
M3HER1@)C"/4[D)1E5F(IMK-_8I=6]S#9K/`UW:7"1S1RR+##+&H`>6-I7085
M*R$,"%`-=H-"N%NVOO,!I\DR6TO*K>X0<K.-5&(U"BK$4..@WF6$W4\=I@N'
MCN'AD6VG%H"UQD2TI)E*K,:"C!28RU-IFTZTO(@L<<@,\#Q"2*4$QR1,:HZM
MA-0&QINQJM17]S@\R_2?9IN6Q8<'][&?2N_,_1^C!M\+>8S<SS#J''BP?]PS
M/'CI_4?H</9QV^-?V<S_`+7TON2S:8<C.N*\KA[.<Q9G]9E8NW;X>?:GFOL!
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M[?S&1CX^YR<W/\5-NML/+YW,P8^1IY5BRC7D\/AS:UYO#X<S!A\-/N/_V@`(
M`0$!!C\`_HJOY5^RC&+<O.N]D'2#-HB4/$3*N7)TT4R@`?$1#A1&\;KMOT`\
M2$X'C%LKTQW,`9/^V7R6.EWDL)P_<"(B/!TEMRC>PNBB8O;5+'64I\#&+_=?
MMJ86($IM/`W<<H_OX4",:Y[MPE`>0T#CF";)JB'PY1LUYKZI0-_ZB!_X<'""
MV^;AY(`$0(:4)CV(`X!^(]C;I_E`?](\<D7M+R*\$PZ)@^R3`1QS_N^1"IR>
M@C_`1X`8[8M>7I1TT$F84?$/WATL2+Z^/'YNP;(A"^'B3+?4'^/@;#Z7P#^/
MCP`SFRO*D64/[9D<@QKKE\=!T!U1HP!TT'XB'`$F]NN?6!@$`5)$N*!,')^_
M0KVQP',(?Q$NO"82]<W%5$YM.H::QY57:"6NFNJE?R%,K'*77\$]?X<5F+VO
MVFU@7<YD*:HCJ8D8.PT>6&@XS2@9C(!8X'Z#1TZC9>=GHB'561,=D];FDV@G
M.*2Z853!UASCMYJ&ZB19MK#N)A[%D.BU_)#*_P`VFG)FQ].IS$HSE##C=D\1
MAQ9)&,W1>MG*H%!=9<QDY2N3<18(Q8`%*1A))E*L50$-0%-VP67;G`0\0T,/
MA_4*N'"J2#=!)19==90J2***11.JJJJ<2D323(41,81```-1X?Q,]FEGDRX,
M.L16EX5;)Y#DP<H>"C-S/,W;2BQCQ-3Y3HNI9%<AM=2>`\/8[;=MLK5>0Y3I
ML;/F&Q25I?+<XG`JYZ?435=I&KIEY1`HR[\@FUUU#XKQN'+!FN2C'"IVIFFW
MO':=/@X4PJ&`Q7MXJD$UE(PA#&Y>I(3'RZ>)OCPTFMPV18JH)N!*Y<K9OS/-
MY&M*93:*`=-I5S9!3.[\=>1P];&*/]H0'A!;,NZ^X3ZQ]!<QV-Z#$U@J'PU3
M;SMIF[?W.GX'/&I:_'D_#AN$]4,I9,51%,QEKKE&78"L<F@B*B>/&U$3Y#F#
MQ+IIIX<$2B=G^('I$].4+9%2-\$=/AU#7F3L1E?_`'".O"9:MMDV^UT$0`$S
M0N&\=QJA0+\/S6E=24$0_>(Z\%)$4RJ11"``$)&UV(8E*`?`"E:LT@*`?PXY
M44DDBAX`5),J90#]VA0`/V<JJ::I?[JA"G#_`,C`(<&)+T^K2A3Z@<LC7XE\
M4P&#00,#EHJ!M0^.O"A;/MJP#8@5`04&;P[CR4,;F\!U.]KJQM1_?KKQ!8ZQ
M93*Q7-HNSJ4>^2T^G0<=#T!G1<.VQW-S!F$%&-F\"M&99SS8UU5A(FF=U'3`
MG-S]+7BV7F4JV4:G<;Q89NV6>Q53*EA<OI2QV.1<RTU+*IW@+HQ(Y?R3M58X
M$1*3G..A0#PX7FMLV]K-N(YLIA6:.)R(:3+L52B'3(I.T6=QF[;\I?`%"MU#
M%T#Y1X(OA7>%7MQU?CR:-J]<+>ULD\_;I%,0K1RVSW7%6;$!3*'+VL]S@/P.
M`\)--^/V^GZE?:'%%_?Z;'6J@QP)%Y@,Z+8U$\C8ZGWB8Z:I-'3%(X>(&(&G
M#"'D\D26";<]Z:85_-\6G5H_N#"4ABDN\>\F:,BAU#`!#/)!DH<!UZ8#J`,9
MN`E8V<A91NF\C9>'?-9*+D6BH<R3IB_9*K-';=4/$ITSF*8/@/[4FED`V0LW
MV.*4D*-AR#?HM)!RU,=5NWL-SEA2>%J%2.Z1.FFN9!=T\43.5LW5*DNHA),L
MEY(>US&SM=7LL.X^4=UC'C9H8Z@H-Y2-;NE7UO<(E4\%YAP_5*81Z8IE$"!%
MWQ1FCA;!DCTG"&5;\Q=G5LK(YCE47Q]44U&LK;RE$H:.CJ,8H_S%*]%4AD^(
MV3F<=CG^^M.BLM;LU%:V.+*[3/UA-%X^311I#1JFN`&1[MI(.TN4/U)AU$13
M;HPE5JU=C5E13138P<!!1$>B=PX5$A`:QT7&LFZ9CG-\B29"B(Z``CQ);4OM
M0UJ;0KS%=VPE<O14<Q):[,Q9NTVC^V(V"Q%2@\38[*J8"MWK@4)1?G2-UVRJ
MP,@2LV3]_31M;Y`1=/6[G*6;;F\:JK")S).)MTQ9`HX3$=#`CU$0'P(<Q=!X
M/-5C?^Q4G8HIG\*1/(6;(59:1:!UV:02:#-P>-,HX3*4%BE/TQ'FT\.,<(Y%
M/U,@HT.H)7I05&RW4N2=?CR6<_69%(S5YYL%QYD0!(WQ('+I_0?P\LS0D(N4
M9N8^18NDRJMGC)XB=!RV73-\ITED5!*8/Q`>!V_VB^7=YM9W'K,8FC1UOMU@
MGX6*K>3W)@QO(-_/7[TO>T+);`];4D7"AG`1B;M910>L;7C,V5(^0!A>9:&-
MCC%QB*E2=^X5[1<Q,5(L.<Q2JNJI&]Y-\@C\Z<8</'70;)N+LT<*%TW+6,74
M.HY1,1VTQ?1G4C#P!0*MJLW&>LZTJ\,)=".F8,5/F`I!_H*MW"2:Z"Z9T5T%
MB%51615*)%$E4S@8BB:A#"!BB`@(#H/$D\M&$H;'=T?]14,AX:(UQU94WJB9
MDS/WK"+:'J%@=G$0$RDG&/%!Y0T,`^/$IE383FNPYXPC'+N9JQ8K)'KOY0D>
MGU'#L]CPR\<2D+;-$3BF:3KR@30ZG4(BT*`G!MB?($4TPON<;-W(GH;EXJ>K
MWX(Y$ZT@\QW)R!BO?,6R")UW$([$SUN@4QT5GJ:3A5+C*N;,D.'ZELR!<IF;
M>,I!5912`9G='0B*LV*N`*-XVJQ"*$<U1$`Z+9JF3_5XN&3LRQ2%BP_M[0K<
MDYIKX@*1E[OEF7E#5:&FT#?*_J\4VK[Q[(-A^1RH1LW5*HW77(9LR9-D&;-F
M@BU:-&J*;=JU:MTRI-VS9ND4B2"""1`*0A0`I2@````'[+%7ZP_7C9K/=ZKN
M&5GC0XD=(U>3C9ZUV]`I@`2BVFX2IGBG)1\#M9%0OQ'4,3SK.(;$R/GZKU_,
MF1[&=`@2DD6W1X3-(@3KF`RZ,75JC)-TB-N<4BOEG:Y0*9R?AY1LJ;F\#X[N
M<<DV6D:I<LJTFO6*.3>(D<M#/X:3F6T@R%TV4*JF"J9!.D<IP`2F*(I-T=Z&
MU\ZRZA$DB!G#'0"=10P$(4!-80*`F,(!XCIP^SQF2U$:4XHLVE::07;R\]?9
MN4:JO(>OTIB5RBA,2$FT0.N505DVJ+5-1PLLD@F=0LI;=N'V\IBV8CBWKA%2
M;/!96R*Y!JT4T44E++1XB)K<$[,E\RB)TERMQ'03J`',)L.6>IR&"MPZ#5^Y
M;8_G)4DQ!7$D.BHM,$IEA48Q#I::C&[=5PXBG;1%RFV3.HB=R1%P=&+L&2QD
M+;?K=W),?8FK"[1.S6?M#$3=RKUTZYFU<JS!94A%WRQ%3F.(D;H.5"F3+[M&
M^W8N&!>EYGZF\JR\$5Y/IU.M[LC`^C.3I#_M'EO3_'D_#B)W>X!:RU4SULUL
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MOZV+M*V4M9A99N?>-+G"D9'=H`D\60D69%Q3!,6Y1<XZPUA&G5[+VY;(CEH^
M+39@DU)Q=5K#UP:/AU92(J[Z.G92RW&6_)BV"#A-04D55E/`S9-S`V3=>TQ;
M7LHV%DVE7U$Q1#V)G"T9%VGUTJ_*S-CMUJ6L%B:)*%*^5;"BR2<%.F@*Z90<
M*<5K[D6W1+VQR?2\AU7W66J7)"ED9.2E40IV5HXK0J:;"Z1UO3:M7JJ9=9$[
MQ%R?19%8[C_#JR_^@E_]VXOF[7;56)&[8=O,Q*W/)5)K[-9_8L3V26<JR5CE
MVT0U(HX?XZD'ZRKLJS8@A#`<Z*R:31))8U[P?F&9952@[B4ZNWAKC,+I,XBK
M9(JJLNC7FTX\7%-*,A+6RL3EJJ[5-TV[Q)H*G30,NLF`@("`@`@(#J`@/B`@
M(?$!_8UN<"U<.SX2S%3K_.I-DC+G+6)6+L5`>N!13*=04VDQ;F"BA@#1)$IS
MFT(4PAMRL$#)-G<OC_'U=PW>8](Y!>0MOQ="Q]6<(2*!#&[569AV3.50*(^+
M202-\1$`RUF[+^8<Z+7?+&3[Y?WC.D2U*A:Y"1]HLLC+0U?8M[!1[3*.!A8M
MRDW.N=R4BIR")$DR<I0JF:</WO,]ALTQF.MX^=QV09JF2<*$/,U.\SR[MNG7
MJ16'R,DB\K"!2&,L=+IJ*`).;E,7['.SF_S<BWQ!([0=ILK*,^_7;*/E\F+J
MQ]T.Q<%.44I&4K='81C-;4YD%TOE#XE&E3]GILLPHR,M%8RQIC+$U?ATU^HA
M%O7Z;*,8O)""@HB&B8J,446547)\PE*4JBB@`.WG=GM#Q1DC#V7ZQ:X.4R,Z
ML,?6(Q.\V*MV6"D:7/)-:;/31I&<<MBNF,LHY`HOFB;1,P*`537*]>SVV1M%
M%P!%2;RJT&>33=P$E'XJB*Y$URO+L'`"F[A7-NLJ]C<-#@=!V<RY%2'064((
ML1;-Q8BW[068HI]J+7I]'MA;\O1[?H_)R:<O+X::<1&$<<0C-IA'=Q1Y"I90
MQ3%%!G70IF?*19*[>*>5FTY"LH,EDC"6!JU3`B+(2MR)%*BBF4-_&R;<+-*-
M*;CF+ON8JN]=G09>;2N*():7<K03)10G4D<NXG[*29I:"=0(QNB4.HJ!3?=/
M^[-:2K!>'<%.XNQY,I=P88B[;B;E7:YE&<JKS\IW$.<>XTNQ(Z.52,`(-ID0
M)R&0+RU+.D-%13W*.?)BZR-SM_11<3*$-4[S/4V#IB#\2]=I#L?31GZC<H@!
MWKQ0Q^8")<F=Z?DF(BW!JYC>Z7REV5Z@CWU'NM/K<E.P=DC)`Q0<1Z:;E@"+
MXJ9TP=1ZJ[<X\BAN-Q)`'7DSXW+K^_EH=?#7_3IQ0_N(8VO,;B+<'3;I3*T[
M%H^/#S>3WS)<KBGSM8.T(*JN1L?)1?6,L(%%:$:B)U2BP;)*YPW[[E<E1F4M
MP-%LC%[`4:5!#S:.G9]@";3+#Z(*T:QB,)7634(FMMV93-HU=N8W2;&:QQC<
M&.<Q2D*43&,80*4I2AJ8QC#H`%``\1XA=N4"V=M]I4-=8*V;A,O"*K1GE16C
M3*4K"X3PNL`$7L+=S9&*3BP6EL8D;%@S(U9+/'IG23/_`/*L?_\`"4)_N7[)
M6W1U=<X$RQ(F5=*WS%#5BPBY:24,*@O+5052I5N8456,91==GY9(.5#<RKHP
M\,:.WC:K]Q7:_`E3;1,5$68]5SC28%$R:1$JXG;3'>JM&38H]"$(M8T2$*1%
MLHT(`CPPI%TL=@VTY?=D(57#.Z.MO\(WLCLQP1%G%J6X&M6M2QE]2D+$R3U0
MP:")"\Q0&RT6YP\=:Z/>ZY*5JRP;\H.8N?K=ACUH^38+],Y1.U?Q[HQ>8A@,
M`&YBF`=!XN&8-I#"7SCM&N+TCNP0ZT3(6F+2K[5RLNRALM5R".VE*Y8JT@[5
M296AB"+10I]1.F#AQ'`T4O.U7)\-8>BF#YI5;G7;'#]P!"@L=J^EHNKO`2,I
MJ)2F;B)0\!,;XC6L*4+#V3*+-PF7*YD1:8MCRNN8Q6.AJM=H!=@FE$N7#KO%
ME[0D<HB`$`B1M?$0X^VIO&VCJ.YO<-MEVXX<CEX>I+HO+3,P52C(N<CUZ@"7
M7[J[8JO3=\?RLH"Y<"Y<)D*9TV2;+XV@_N&;)K/>\G84EI)RO`Q3*M3>.)6[
M+PZM<D;'.XTR$>,"*E&K598$(]TI)HLW"IE2F!0J72@)Z"^W`>G3$5*L7L=:
MJ_@G;HRFZ^Z0<)G2EXIVPDF+UN^8&#J)G2624`Q0Y3%'QXQ3]Z7[>K=3)E4N
M58J5TOT57XU[/%.Q?5!K">HI:MQQTY"1QW?,?*(MI;H%(YBGB:SI15$ZB:S?
MN"[4L@^[8QW($`-TA/;[SD4>3G]4A%^HQC^Z^;I^3@H)/DZFOS\6G[KF]"!>
MU5](%E5\-5.6BWD&YDI"7@#4^.F8BNR1SO8C'=*HRIV,0+D#+2*ZB+LBJ@HG
M7<8.W7X^K[N0>WMRRP1D!I$,U'+I[;$"NY+&<CVS8BBSN1G(<K^-.H.@%+%L
MDBZF.`<1&P^W)D2:VC$,G7LF3,81%PY#)%W;JS=HM4:JKJ1XXK=R>]2*,L)@
M(@P:D'4A`#BU[4=TF%9K)NWZ2M<E8,>VFONEXY`3/2@5W8<765^R<0E@A)]L
MT27>03D[5TP>"8YS-5SN4UY_:=L7VXY/C39)@Y)ED.;<(%LN0)&BD:*+62`B
M("K(OHVMPTBP2.E)R*[QUU(]15$"(<XJ<;JK#D:]52E0U/RVPM-H?V2=CXI*
M$KSBCQC=I,/P=+D428OW48X1;'T'N5T3II<YPY>.HNG8Z_L-VW./E34*\BSK
M5%9_\J8AJF+7).<'T/J80Y%(J':Z:JJ1X=S1?N![)H%5'!5IGDX.\XRCB/!K
M57?39D@G<;339L5PHCC;(J+7K12PE4")EDRII`BJA&=2%LF--JNXRNI2S&->
M+R6;JW#X>J#`7B1#N"MYR9F)*?M31L<PE*Z@X:4;J\NO,7X`6+OK:'EA=&(I
M)13!-Z$`L4H@8L>X1>+B>98E,'YA7!"I./\`61*'R@@U:H(MFK9%-NV;-TR(
MH-T$2%310013*5-)%),H%*4H`4I0``#3^BXK=_I]6O-==_[5`7"OQ-FA7/X?
MJ(N::/6*WA_>3'A0V)&MMPD51P#D8W$UWLM5J)%`$1T3QL9^_P`8D((C\/)O
MX?#@4W=X5L[/4`*-@K\0C*@0-`T,_K1*_'F-H'Q['Q'A>7LN#</6&6=&$[F4
MG,9TJ6D7!Q$1$R[U_".'*IA$==3&$>/\..!O^T&/O^7N$J]1JI6J9`(K+N$8
M.IP4778=)PZ4%5RNE&0[5FR36<*B)E#`0#'-XB(CQYQ>\1XPNLL!"I!*6V@U
M6QR()E`"E3[V8B7CGD*4```YM``./\..!O\`M!C[_E[AI7*=7(&IUYAU`8P-
M:B(^"AF0+*&66!I%Q;=JQ;`JL<QS<A"\QC"(^(CQZS#$>,0N'7[KU7Z"JOJ7
MN>;G[CSWRGS3K\_CS]7FU\=?V-FE@A8F=:LI*.F6;:9C6<FW:3$.[3?Q$JV1
M>HKIH246^1(LV7(`*H*D`Y#%,`#^Q>"ME>@[1".N474-8HEA-Q3D2Z\HKQ\D
MW<M%N7F'3F(.FO"[#']%IM%8NC@JY9TZL0E9:N%"Z\JB[>$8LD5CEYAT$P"(
M:\2+F0P#A1\YEW`/)9P\Q7172\H[!P9V#J157@3J/7`.CF5YU1,;J")M=1UX
M6AL?TJI46(<.SOW$53JW#UB-7?*)I(G>+,81FQ:JNSHHD(*ABB<2D*&N@!QT
MUDTU4^8AN14A5"<R9RJ)FY3`(<R:A`,4?P,`"'C^V/OD'EV?QVXC(FO-&:4+
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ME?=SN)D<3Y/K#KU`6$I%,QA/WJ)SK8*N@2:&1++UQK44UF7>N7+8A7',J"A-
M!XQ-O"N6)]M[W9GF#/:.)H:/J\GDZ&W"055G,HS.,Z_?'S6>6DZ/-)$>1!UC
MMFO(L\*9,2%;IJ'40ON&:O$[68-GCW<4^P\;;1DR=NF/MT5_QA$R)&CK.F/+
M9;96`QE8VTS%\\M&0S)B\47C4C\JZ@]-12;H&1YJ6@):O8$NVY*4D#0;UQ`I
M8RQ]*MH>RKHR:`'!W8&[UZB"4<D0[E?JI@0!,H0IJ'$3%-W!Q,9>5</L%[M*
MX.N<91J/8,[LHN1QE5+Q89!LV3862;:3307#=DF_",57!%Z9NN4Z99&E'?Y%
MBZPQE,BP#?.\QC*V1^W::L>)(B6G,CP4-E]5EZ;=.:M'0#TRC@XIQ[D[4Z;9
MPNH)"FRS?*JCD;'TS5<71&3<<R6<L$90A:MD>JW.VP6/:+?ZA%1Z4?/W>DS%
MSM4:@"319G).$70*)I@F!U"0>&+`&1WER-G9GM2LV0*]B.Y)X/8[D#)-VJM#
M0OCWN8]LYE)<'!6C45W+M!NW.LY!-`H.#R<:I9[K`5%.$RW/U/+]CQW:(S#^
M4X_!$3)3V73XJNW9KHW8:3"PSQTL+=$$W2+506AG'R@:6>T"K9;K+:/A:Q:8
MUSD[&TY26%OI]S:N'M9MM+F'7=0MBAY)NV,)B(N>\:")2N4$3&`H_P!7%>X'
M<=;_`"\'WM7YOY/Z*ZWOR3UMT>[_`%WK?H='X?E^5\WXZ\?;*]4^>>J?>C[H
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M8^ZWE/FO_P`78]?7Y^3AI[V>7^E_\V:C^BO=+R7ZE^CWS?TAY;YS_,?HW\\[
M+TGZ?_2=/7S3\_H<9.]:^_\`_E<>Q>]OV`]N/;?U[V'GF1/4'U,<WYWJ+U!Y
MAZ0Y?Y?YGR^9?E<W&%?K@]9>V_O_`/;J\L\@]NO83Z=?6L;Y=U?3?ZKW5]5>
M4^K.Z_*[3I>6_I].-B?N3YIVW^9]O6]^>X\MZGU2]+,_I'S+MOS.Z[?G[3H_
MGZ\FGS:<3'H?VH[_`.GW-WT=>VWT1_5%YCS3FOU/>J/YGZ^]K>_Z_+_)?3GF
M'F'YO+QO*ZOH_P`]];8C\^^G#M/H;[OT+(Z?3KY;_*O6G-S^O.T_2>8=EVWZ
&;H_T/__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
